We are proud to announce the appointment of Nobel Laureate Professor Roger D. Kornberg, to our Scientific Advisory Board. This appointment marks a key milestone in our commitment to advancing scientific innovation and improving the lives of individuals affected by neurological disorders. #NitricOxide #Autism #AlzheimersDisease
NeuroNOS
生物技术研究
Developing innovative therapies for individuals with Central Nervous System disorders including Autism Spectrum Disorder
关于我们
- 网站
-
https://www.neuro-nos.com/
NeuroNOS的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 类型
- 私人持股
动态
-
Check out our CSO Prof. Haitham Amal in a fascinating podcast talking about #Autism #NitricOxide, treatment strategies and more.
Visiting Professor at Boston Children’s Hospital and Harvard Medical School, Associate Professor at Hebrew University. MIT alumni. Drug development for brain disorders Co-Founder & CSO - NeuroNOS & Point6Bio Ltd.
With Doctor #Podcasts talking about #MIT where I started working on #autism and #Alzheimer’s and on the progress of the Amal team at The Hebrew University of Jerusalem. Lastly, on how I spend my time at Boston Children's Hospital and other exciting stuff. https://lnkd.in/dkWAMg6v
Autism causes, diagnosis and future treatments; with Haitham Amal, Ph.D.
https://www.youtube.com/
-
A reunion meeting of our CSO Prof. Haitham Amal with Prof. Steven R. Tannenbaum from Massachusetts Institute of Technology, the living legend who co-discovered that the human body produces #NitricOxide. At MIT, Prof. Tannenbaum was the mentor and supervisor of Prof. Amal
Visiting Professor at Boston Children’s Hospital and Harvard Medical School, Associate Professor at Hebrew University. MIT alumni. Drug development for brain disorders Co-Founder & CSO - NeuroNOS & Point6Bio Ltd.
A great gathering with our MIT legendary mentor Prof. Steven R. Tannenbaum. Uthpala Seneviratne
-
-
Kudos to our Chief Scientific Officer, Prof. Haitham Amal, for the incredible work that has garnered extensive media attention! NeuroNOS stays committed to the development of new therapy strategy for #Autism #Alzheimers and other brain disorders.
Visiting Professor at Boston Children’s Hospital and Harvard Medical School, Associate Professor at Hebrew University. MIT alumni. Drug development for brain disorders Co-Founder & CSO - NeuroNOS & Point6Bio Ltd.
Thanks to the Fox News Media for the personal Interview and for featuring our Review which presents the epidemiological and biochemical studies in the field. Still, extensive work should be done to prove the link. For the full interview: https://lnkd.in/dZnY-WwD
-
-
Did you know there is a link between #AlzheimersDisease and #AutismSpectrumDisorder? We at #NeuroNOS are eager to develop a therapy for these two major disorders. Check out the National Institute on Aging (NIA) workshop summary, including a fascinating talk from our CSO, Haitham Amal https://lnkd.in/gWAGZWiv
-
-
NeuroNOS转发了
Meet Prof. Haitham Amal, the CSO and inventor of his latest company, NeuroNOS. As a professor at HUJI Pharmacy, Prof. Amal leads research that develops innovative therapies for individuals with Central Nervous System disorders, including Autism Spectrum Disorder. During his recent visit to Boston Children's Hospital at Harvard Medical School, he shared insights on his revolutionary discovery that excess nitric oxide in the brain is linked to autism. This pioneering research opens new avenues for understanding and addressing autism spectrum disorders. We're looking forward to seeing more on how NeuroNOS is making a difference! To learn more, visit: https://www.neuro-nos.com/ #AutismSpectrumDisorder #NeuroScience #MentalHealthInnovation
-
-
A remarkable achievement for our CSO, Haitham Amal, and his outstanding team at the The Hebrew University of Jerusalem, scoring in the top 5% in the #Altmetric_Attention_Score, with their groundbreaking publication demonstrating that reduction of #NitricOxide in the #brain, can reverse autism-like behavior in mice. https://lnkd.in/gi3ExzkZ https://lnkd.in/gwirNZFe
-
-
Meet the CSO and inventor of @Neuro_NOS revolutionary technology, Haitham Amal visiting Prof. at Boston Children's Hospital and Prof. at the The Hebrew University of Jerusalem. First to discover that excess #NitricOxide in the brain is linked to #Autism.
-
-
Although no FDA therapies are specifically approved to treat the core symptoms of #AutismSpectrumDisorder, NeuroNOS is pioneering the development of such innovative treatments. Discover more at https://neuro-nos.com
-